NDT Pharmaceuticals Inc. (NDTP)
OTCMKTS · Delayed Price · Currency is USD
0.8400
+0.197425 (30.72%)
At close: Mar 27, 2026
NDT Pharmaceuticals Market Cap
NDT Pharmaceuticals has a market cap or net worth of $135.72 million as of March 27, 2026. Its market cap has increased by 284,487.33% in one year.
Market Cap
135.72M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.84
Market Cap Chart
Since October 21, 2011, NDT Pharmaceuticals's market cap has increased from 2.76M to 135.72M, an increase of 4,818.72%. That is a compound annual growth rate of 30.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 135.72M | -48.49% |
| Dec 31, 2025 | 263.50M | 3,007.18% |
| Dec 31, 2024 | 8.48M | -13.47% |
| Dec 28, 2023 | 9.80M | 1,785.32% |
| Dec 31, 2021 | 519.82K | -69.72% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CytoDyn | 338.40M |
| Northwest Biotherapeutics | 330.28M |
| Silence Therapeutics | 232.86M |
| Vaxart | 156.38M |
| HST Global | 88.40M |
| BioStem Technologies | 74.59M |
| Nuo Therapeutics | 69.54M |
| Anebulo Pharmaceuticals | 36.17M |